Nucleic Acid Isolation Markets in Europe

Table of Contents

• 1. Executive Summary
  • 1. Industry Snapshot
    • 1. Key Findings
• 2. Glossary and Exchange Rates
  • 1. Glossary of Terms
    • 1. Terms
  • 2. Currency Exchange Rates
    • 1. Exchange Rates
• 3. Total Nucleic Acid Isolation Market in Europe
  • 1. Market Overview
    • 1. Key Market Trends
  • 2. Research Methodology
    • 1. Research Service Methodology
  • 3. Segmentation
    • 1. Market Segmentation
  • 4. Market Engineering Measurements
    • 1. Market Engineering Measurements
  • 5. Industry Challenges
    • 1. Key Challenges
  • 6. Market Drivers
    • 1. Market Drivers
    • a. Need for More Sample Purity Spurs Market Growth
    • b. Emerging Trends in Translational Medicine Providing the Impetus for Nucleic Acid Isolation Protocols
    • c. Preconfigured Dedicated Solutions Aid Smaller Research Laboratories
    • d. RNA Extraction Markets Witnesses a Positive Growth Trend
  • 7. Market Restraints
    • 1. Market Restraints
    • a. Gearshift to Proteomics Approach Thwarts Nucleic Acid Penetration
    • b. Gradual Shift in the Application Pursuits Deter the Market for Nucleic Acid
    • c. Funding Insufficiencies and Some Anomalies in the Research Spending Cause Some Concern to the Suppliers
  • 8. Revenue Forecasts
    • 1. Revenue Forecasts
  • 9. Pricing Trends
    • 1. Key Pricing Trends
  • 10. Technology Trends
    • 1. Technology Trends
• 4. Nucleic Acid Instrumentation Markets
  • 1. Market Engineering Measurements
    • 1. Market Engineering Measurements for the Instrumentation Segment
  • 2. Revenue Forecasts
    • 1. Revenue Forecasting Analysis
  • 3. Competitive Structure
    • 1. Competitive Landscape
• 5. Nucleic Acid Consumables Market for Isolation
  • 1. Market Engineering Measurements
    • 1. Market Engineering Measurements for Consumables
  • 2. Revenue Forecasts
    • 1. Revenue Forecast Analysis
  • 3. Competitive Structure
    • 1. Competitive Landscape
• 6. Strategic Recommendations
  • 1. Key Strategies
    • 1. Competitive Scenario Analysis and Strategies
• 7. DSD for Nucleic Acid Isolation Markets
  • 1. Pharmaceutical R&D Expenditure
    • 1. Pharmaceuticals R&D Expenditure
  • 2. Pharmaceutical R&D Expenditure as a Percent of the Pharmaceutical Market
    • 1. Pharmaceuticals R&D Expenditure as a Percent of the Pharmaceuticals Market
  • 3. Number of Biotech Companies
    • 1. Number of Biotech Companies
  • 4. Private Investment in Biotechnology
    • 1. Private Investment in Biotechnology
  • 5. Government Investments in R&D
    • 1. Government Investments in R&D
• 8. Database of Key Industry Participants
  • 1. Key Industry Participants
    • 1. List of Industry Participants in the European Nucleic Acid Isolation Market